Your browser doesn't support javascript.
loading
A molecular mechanism explaining albuminuria in kidney disease.
Butt, Linus; Unnersjö-Jess, David; Höhne, Martin; Edwards, Aurelie; Binz-Lotter, Julia; Reilly, Dervla; Hahnfeldt, Robert; Ziegler, Vera; Fremter, Katharina; Rinschen, Markus M; Helmstädter, Martin; Ebert, Lena K; Castrop, Hayo; Hackl, Matthias J; Walz, Gerd; Brinkkoetter, Paul T; Liebau, Max C; Tory, Kálmán; Hoyer, Peter F; Beck, Bodo B; Brismar, Hjalmar; Blom, Hans; Schermer, Bernhard; Benzing, Thomas.
Afiliación
  • Butt L; Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Unnersjö-Jess D; Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Höhne M; Royal Institute of Technology, Stockholm, Sweden.
  • Edwards A; Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Binz-Lotter J; Department of Biomedical Engineering, Boston University, Boston, MA, USA.
  • Reilly D; Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Hahnfeldt R; Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Ziegler V; Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Fremter K; Institute of Physiology, University of Regensburg, Regensburg, Germany.
  • Rinschen MM; Institute of Physiology, University of Regensburg, Regensburg, Germany.
  • Helmstädter M; Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Ebert LK; Center for Mass Spectrometry and Metabolomics, The Scripps Research Institute, La Jolla, CA, USA.
  • Castrop H; Department of Medicine IV, Medical Center - University of Freiburg, Faculty of Medicine, and Signalling Research Centres BIOSS and CIBSS, University of Freiburg,, Freiburg, Germany.
  • Hackl MJ; Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Walz G; Institute of Physiology, University of Regensburg, Regensburg, Germany.
  • Brinkkoetter PT; Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Liebau MC; Department of Medicine IV, Medical Center - University of Freiburg, Faculty of Medicine, and Signalling Research Centres BIOSS and CIBSS, University of Freiburg,, Freiburg, Germany.
  • Tory K; Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Hoyer PF; Department of Pediatrics and Center for Molecular Medicine, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
  • Beck BB; MTA-SE Lendület Nephrogenetic Laboratory, 1st Department of Pediatrics, Semmelweis University, Budapest, Hungary.
  • Brismar H; University Children's Hospital, Clinic for Pediatrics II, University of Duisburg-Essen, Essen, Germany.
  • Blom H; Institute of Human Genetics and Center for Molecular Medicine, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
  • Schermer B; Royal Institute of Technology, Stockholm, Sweden.
  • Benzing T; Royal Institute of Technology, Stockholm, Sweden.
Nat Metab ; 2(5): 461-474, 2020 05.
Article en En | MEDLINE | ID: mdl-32694662
ABSTRACT
Mammalian kidneys constantly filter large amounts of liquid, with almost complete retention of albumin and other macromolecules in the plasma. Breakdown of the three-layered renal filtration barrier results in loss of albumin into urine (albuminuria) across the wall of small renal capillaries, and is a leading cause of chronic kidney disease. However, exactly how the renal filter works and why its permeability is altered in kidney diseases is poorly understood. Here we show that the permeability of the renal filter is modulated through compression of the capillary wall. We collect morphometric data prior to and after onset of albuminuria in a mouse model equivalent to a human genetic disease affecting the renal filtration barrier. Combining quantitative analyses with mathematical modelling, we demonstrate that morphological alterations of the glomerular filtration barrier lead to reduced compressive forces that counteract filtration pressure, thereby resulting in capillary dilatation, and ultimately albuminuria. Our results reveal distinct functions of the different layers of the filtration barrier and expand the molecular understanding of defective renal filtration in chronic kidney disease.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Albuminuria / Insuficiencia Renal Crónica Límite: Animals / Female / Humans Idioma: En Revista: Nat Metab Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Albuminuria / Insuficiencia Renal Crónica Límite: Animals / Female / Humans Idioma: En Revista: Nat Metab Año: 2020 Tipo del documento: Article País de afiliación: Alemania